New insights into the pathophysiology and development of novel therapies for sickle cell disease

S Moerdler, D Manwani - Hematology 2014, the American …, 2018 - ashpublications.org
Although the seminal event in sickle cell disease is the polymerization of abnormal
hemoglobin, the downstream pathophysiology of vasoocclusion results from heterotypic …

Biochemical and therapeutic effects of omega-3 fatty acids in sickle cell disease

AA Daak, MA Lopez-Toledano, MM Heeney - Complementary Therapies in …, 2020 - Elsevier
Sickle cell disease (SCD) is a hematologic disorder with complex pathophysiology that
includes chronic hemolysis, vaso-occlusion and inflammation. Increased leukocyte …

[HTML][HTML] Effect of omega-3 (n− 3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial

AA Daak, K Ghebremeskel, Z Hassan, B Attallah… - The American journal of …, 2013 - Elsevier
Background: Blood cell aggregation and adherence to vascular endothelium and
inflammation play a central role in vaso-occlusive crisis in sickle cell disease. The …

[HTML][HTML] Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease

BT Kalish, A Matte, I Andolfo, A Iolascon… - …, 2015 - ncbi.nlm.nih.gov
The anemia of sickle cell disease is associated with a severe inflammatory vasculopathy
and endothelial dysfunction, which leads to painful and life-threatening clinical …

[PDF][PDF] State of the art paper Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects

AFG Cicero, A Reggi, A Parini, C Borghi - Archives of Medical Science, 2012 - termedia.pl
Abstract n-3 Polyunsaturated fatty acids (PUFAs) are organic acids, essential for mammals,
whose deficiency is associated with different diseases. The American Heart Association …

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

AA Daak, CD Dampier, B Fuh, J Kanter… - Blood …, 2018 - ashpublications.org
Blood cell membranes in sickle cell disease (SCD) have low docosahexaenoic acid (DHA).
DHA treatment reduces sickle cell crisis (SCC) rate and ameliorates the inflammation …

Omega 3 (n− 3) fatty acids down-regulate nuclear factor-kappa B (NF-κB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell …

AA Daak, AY Elderdery, LM Elbashir… - Blood Cells, Molecules …, 2015 - Elsevier
Chronic inflammation and reduced blood levels of omega-3 fatty acids (n− 3) are known
characteristics of sickle cell disease (SCD). The anti-inflammatory properties of n− 3 fatty …

[HTML][HTML] Dietary alpha‐linolenic acid reduces platelet activation and collagen‐mediated cell adhesion in sickle cell disease mice

S Stivala, S Gobbato, N Bonetti, GG Camici… - Journal of Thrombosis …, 2022 - Elsevier
Background Sickle cell disease (SCD) is a genetic hemoglobinopathy associated with high
morbidity and mortality. The primary cause of hospitalization in SCD is vaso‐occlusive crisis …

Precipitating factors and targeted therapies in combating the perils of sickle cell disease---A special nutritional consideration

SA Khan, G Damanhouri, A Ali, SA Khan, A Khan… - Nutrition & …, 2016 - Springer
Nutritional research in sickle cell disease has been the focus in recent times owing to not
only specific nutritional deficiencies, but also the improvements associated with less painful …

Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double‐blind, placebo‐controlled trial

MM Arruda, G Mecabo, CA Rodrigues… - British journal of …, 2013 - Wiley Online Library
Erythrocytes from sickle cell anaemia (SCA) patients continuously produce larger amounts
of pro‐oxidants than normal cells. Oxidative stress seems to primarily affect the membrane …